SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No.5)
Bio-Medical Automation, Inc.
(formerly OZO Diversified Automation, Inc.)
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $.10 par value per share
- --------------------------------------------------------------------------------
(Title of Class of Securities)
O9056V105
- --------------------------------------------------------------------------------
(CUSIP Number)
Steven N. Bronson
16 East 52nd Street
Suite 501
New York, New York 10022
(212) 872-1623
with a copy to:
Steven D. Dreyer, Esq.
Hall Dickler Kent Friedman & Wood LLP
909 Third Avenue
New York, New York 10022
(212) 339-5580
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
October 29, 1999
- --------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
statement because of Rule 13d-1(b)(3) or (4), check the following box: |_|
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
CUSIP No. O9056V105 SCHEDULE 13D Page 2 of 5 Pages
- --------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Steven N. Bronson
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |_|
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
PF
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(d) or 2(e) |_|
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
USA
- --------------------------------------------------------------------------------
7 SOLE VOTING POWER
92,653
--------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY -0-
OWNED BY --------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON 92,653
WITH --------------------------------------------------------
10 SHARED DISPOSITIVE POWER
-0-
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
92,653
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* |_|
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
14.4%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
Page 3 of 5 Pages
SCHEDULE 13D
Except as expressly restated and amended below, the Schedule 13D and
amendments thereto, as filed on behalf of Steven N. Bronson with respect to the
shares of Common Stock (the "Common Stock") of Bio-Medical Automation, Inc.
(formerly OZO Diversified Automation, Inc.), a Colorado Corporation (the
"Issuer"), remains in full force and effect.
Item 2. Identity and Background.
(a) This Amendment No.5 to Schedule 13D is filed on behalf of Steven
N. Bronson.
(b) Mr. Bronson's business address is 16 East 52nd Street, Suite
501, New York, New York 10022.
(c) Mr. Bronson is the President of Catalyst Financial Corp.
("Catalyst"), a broker-dealer licensed under the Act. The principal place of
business of Catalyst is 16 East 52nd Street, Suite 501, New York, New York
10022.
(d) During the last five years, Mr. Bronson has not been convicted
in a criminal proceeding (excluding traffic violations or similar misdemeanors).
(e) Mr. Bronson has not, during the last five years, been a party to
a civil proceeding of a judicial or administrative body of competent
jurisdiction and as a result of such proceeding was or is subject to a judgment,
decree, or final order enjoining further violations of, or prohibiting or
mandating activities subject to federal or state securities laws or finding any
violation with respect to such laws.
(f) Mr. Bronson is a citizen of the United States of America.
Item 3. Source and Amount of Funds or Other Consideration.
Mr. Bronson acquired securities of the Issuer utilizing his personal
funds.
Item 4. Purpose of Transaction.
Mr. Bronson acquired securities of the Issuer for investment
purposes. Mr. Bronson is currently in discussions with the Issuer's management
and certain shareholders regarding possible transactions with respect to the
securities of the Issuer. Mr. Bronson has not reached an understanding or
agreement with the Issuer's management and/or such shareholders. These
discussions may result in the acquisition by Mr. Bronson of a controlling
interest in the Issuer.
<PAGE>
Page 4 of 5 Pages
Other than as described above, Mr. Bronson does not have any plans
or proposals which may relate or would result in:
(a) The acquisition by any person of additional securities of the
Issuer, or the disposition of securities of the Issuer;
(b) An extraordinary corporate transaction, such as a merger,
reorganization or liquidation, involving the Issuer or any of its subsidiaries;
(c) A sale or transfer of a material amount of assets of the Issuer
or any of its subsidiaries;
(d) Any change in the present Board of Directors or management of
the Issuer, including any plans or proposals to change the number or term of
directors or to fill any existing vacancies on the Board of Directors of the
Issuer;
(e) Any material change in the present capitalization or dividend
policy of the Issuer;
(f) Any other material change in the Issuer's business or corporate
structure;
(g) Changes in the Issuer's charter, by-laws, or instruments
corresponding thereto or any actions which may impede the acquisition or control
of the Issuer by any person;
(h) Causing a class of securities of the Issuer to be de-listed from
a national securities exchange or to cease to be authorized to be quoted in an
inter-dealer quotation system of a registered national securities association;
(i) A class of equity securities of the Issuer becoming eligible for
termination of registration pursuant to Section 12(g)(4) of the Act; or
(j) Any action similar to any of those enumerated above.
Item 5. Interest in Securities of the Issuer.
(a)(b) Mr. Bronson may be deemed to beneficially own an aggregate of
92,653 shares of the Issuer's Common Stock, representing approximately 14.4% of
the total shares of Common Stock deemed outstanding. With respect to such shares
of Common Stock, Mr. Bronson owns of record 92,653 shares of Common Stock, as to
which he possesses sole voting and disposition power.
The foregoing shares of Common Stock do not include any shares held
of record which may be maintained in the trading account of Catalyst and, with
respect to such shares, Mr. Bronson disclaims beneficial ownership.
<PAGE>
Page 5 of 5 Pages
(c) Not applicable.
(d) No other person is known to have the right to receive or the
power to direct the receipt of dividends from, or the proceeds from the sale of
such securities of the Issuer.
(e) Not applicable.
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information as set forth in this statement is true, complete
and correct.
Date: November 5, 1999 /s/ STEVEN N. BRONSON
--------------------------------
Steven N. Bronson
